所有标记为「pharmaceuticals」的文章
Amgen 表示，现任首席技术官、长期任职的高管 David Reese 将于六月底退休，这标志着这家全球最大的生物技术公司之一迎来一次领导层变动。
Amneal Pharmaceuticals 同意以 3.75 亿美元的前期付款收购一家生物类似药制造商，凸显出制造商仍在通过定向交易扩大产品组合，并在更加难以预
Anthropic 任命诺华 CEO Vas Narasimhan 加入董事会，表明该公司正与制药行业建立更紧密的战略协同。
A newly approved daily weight-loss pill moved through U.S. FDA review faster than most drugs in recent years, signaling continued momentum in the obesity treatment market.
Eli Lilly 与 Insilico Medicine 已签署一项最高可达 27.5 亿美元的协议，进一步深化双方合作，推动 AI 研发药物候选物走向全球市场。
After years of development challenges, oral GLP-1 weight loss drugs are finally hitting the market. Novo Nordisk's oral Wegovy is already available, with Eli Lilly's orforglipron expected to win FDA approval soon.
Vinay Prasad, a controversial figure at the FDA's biologics center and key ally of Commissioner Makary, is leaving the agency.
Pfizer has won approval for a GLP-1 obesity drug in China shortly after licensing the shot from Hangzhou-based Sciwind Biosciences.
